Stories about Chemie

nova-Institut GmbH

5

From Emissions to Solutions: CO₂-Based Graphite, Plastics, and Methanol win big at “Best CO₂ Utilisation 2025” Innovation Award

hubergroup Deutschland GmbH

6

Press Release - hubergroup Chemicals to showcase groundbreaking bio-based Oligomers for industrial UV-coatings at RadTech 2025

hubergroup Deutschland GmbH

2

Press Release - hubergroup takes BOPE films to a new level with the new Gecko 2-Component Varnish

GEA Group Aktiengesellschaft

2

Adaptability for reliable separation processes with GEA Varipond C

Isomorphic Labs

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...

Isomorphic Labs

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...

hubergroup Deutschland GmbH

4

Press Release - hubergroup Chemicals Presents Groundbreaking Bio-Based UV Oligomers at the European Coatings Show 2025 at its Booth and in a Presentation

nova-Institut GmbH

3

“Best CO₂ Utilisation 2025”: Celebrating Pioneering Innovation in Carbon Capture and Utilisation Technologies

GEA Group Aktiengesellschaft

5

GEA Direct Sprayer DS 25: Less Water, Faster Cleaning

LAUDA DR. R. WOBSER GMBH & CO. KG

LAUDA honors Theo Schlegelmilch for 40 years with the company

DHL Group

PM: Alexion und DHL Express setzen in Irland auf SAF für internationale Luftfrachtlieferung von Medikamenten / PR: Alexion and DHL Express Join Forces in Ireland’s First 100% Switch to SAF for International Air Delivery of Medicines

nova-Institut GmbH

6

CO₂ Revolution 2025: Fueling the Future, Capturing Possibilities

DHL Group

PM: DHL Group und Neste vertiefen Zusammenarbeit zur Senkung von Emissionen in der Logistik / PR: DHL Group and Neste to tighten collaboration to reduce logistics emissions

hubergroup Deutschland GmbH

8

Press Release - hubergroup unveils revolutionary DYNAMICA Ink Series

FCL Components Europe B.V.

FCL Components Officially Releases ATEX-Approved Relays

Norgine

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...

pekutherm Kunststoffe GmbH

Pekutherm Positioned for Success in 2025

Pekutherm Positioned for Success in 2025 - Pekutherm Kunststoffe GmbH has embodied sustainability from the very beginning. - As a partner of the Europe-wide Recycling Alliance founded by Röhm, Pekutherm makes an important contribution to the circular economy. - Pekutherm is expanding its recycling capacity and strengthening its presence in European markets to meet growing demand. - Through recycling partnerships such as ...

GEA Group Aktiengesellschaft

More sustainable fuels: GEA wins first customer for Pre2Fuel process

Aurubis AG

Press release: Symbolic start of industrial heat feed-in to Hamburg city network

Norgine

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

EU4Regions

2

5

Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality

LAUDA DR. R. WOBSER GMBH & CO. KG

Antonio Manconi Ten Years With LAUDA Italia

nova-Institut GmbH

6

Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025

Obrist Group

Obrist Anticipates a Pivotal Shift Towards "Liquid Solar Energy" in 2025